Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2004 Oct 13;15(11):1271–1277. doi: 10.1002/mus.880151109

Flavivirus induces MHC antigen on human myoblasts: A model of autoimmune myositis?

Shisan Bao 1,✉, Nicholas J C King 2, Cristobal G Dos Remedios 1
PMCID: PMC7168366  PMID: 1488065

Abstract

Infection of human embryonic myoblasts by West Nile virus (WNV), a flavivirus, caused significant upregulation of class I and II MHC expression as determined by flow cytometry. After 48 hours at a multiplicity of infection of 5 pfu/cell, a sixfold increase in MHC class I expression was induced from initially low levels of expression. In contrast, MHC class II was induced de novo to five times the control fluorescence level. At least 70% of the cells were infected as determined using fluorescence microscopy and anti‐WNV antibody labeling. Myoblasts were > 90% pure as shown by anti–Leu‐19 labeling. MHC class I (but not class II) was increased threefold after exposure to virus‐inactivated supernatant from 48‐hour–infected cells, indicating the presence of factor(s) contributing to the MHC class I increase. These findings may be important in establishing a link between viral infection of human cells and induction of inflammatory autoimmune disease. We discuss the possibility of using WNV as an in vivo model. © 1992 John Wiley & Sons, Inc.

Keywords: major histocompatibility complex, flavivirus, myoblasts, myositis, autoimmunity

References

  • 1. Arahata K, Engel AG: Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16: 193–208. [DOI] [PubMed] [Google Scholar]
  • 2. Arahata K, Engel AG: Monoclonal antibody analysis of mononuclear cells in myopathies. III. Immunoelectron microscopy aspects of cell‐mediated muscle fiber injury. Ann Neurol 1986; 19: 112–125. [DOI] [PubMed] [Google Scholar]
  • 3. Bao S, King NJC, dos Remedios CG: Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with γ‐interferon. Immunol Cell Biol 1990; 68: 235–242. [DOI] [PubMed] [Google Scholar]
  • 4. Blanden RV, Hodgkin PD, Hill A, Sinickas VG, Müllbacher A: Quantitative considerations of T‐cell activation and self tolerance. Immunol Rev 1987; 98: 75–93. [DOI] [PubMed] [Google Scholar]
  • 5. Bukowski JF, Welsh R: Interferon enhances the susceptibility of virus‐infected fibroblasts to cytotoxic T cells. J Exp Med 1985; 161: 257–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Caspary EA, Gubbay SS, Stern GM: Circulating antibodies in polymyositis and other muscle‐wasting disorders. Lancet 1964; ii: 941. [DOI] [PubMed] [Google Scholar]
  • 7. Daar A, Fuggle SV, Fabre JW, Ting A, Morris PJ: The detailed distribution of HLA‐A, B, C antigens in normal human organs. Transplantation 1984; 38: 287–292. [DOI] [PubMed] [Google Scholar]
  • 8. Dalakas MC, Pezeshkpour GH, Gravell M: Polymyositis associated with AIDS retrovirus. JAMA 1986; 256: 2381–2383. [PubMed] [Google Scholar]
  • 9. Dalakas MC, Pezeshkpour GH: Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol 1988; 23 (suppl): S38–S48. [DOI] [PubMed] [Google Scholar]
  • 10. Eager KB, Williams J, Breiding D, Pan S, Knowles B, Appella E, Ricciardi BP: Expression of histocompatibility antigens H‐2K, ‐D, and ‐L is reduced in adenovirus‐12‐transformed mouse cells and is restored by interferon‐γ. Proc Natl Acad Sci USA 1985; 82: 5525–5529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Engel AG, Arahata K: Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984; 16: 209–215. [DOI] [PubMed] [Google Scholar]
  • 12. Flyer DC, Burakoff SJ, Faller DV: Retrovirus‐induced changes in major histocompatibility complex expression influence susceptibility to lysis by cytotoxic lymphocytes. J Immunol 1985; 135: 2287–2292. [PubMed] [Google Scholar]
  • 13. Forsum U, Claesson L, Hjelm E, Karlsson‐Parra A, Klareskog L, Scheynius A, Tjernlund U: Class II transplantation antigens: Distribution in tissues and involvement in disease. Scand J Immunol 1985; 21: 389–396. [DOI] [PubMed] [Google Scholar]
  • 14. Fukuyama Y, Ando T, Yokota J: Acute fulminant myoglobinuric polymyositis with picornavirus‐like crystals. J Neurol Neurosurg Psychiatry 1977; 40: 775–781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Gamboa ET, Eastwood AB, Hays AP: Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 1979; 29: 1323–1335. [DOI] [PubMed] [Google Scholar]
  • 16. Goldstein SAN, Mescher MF: Cytotoxic T cell activation by class I protein on cell‐size artificial membranes: Antigen density and Lyt‐2/3 function. J Immunol 1987; 138: 2034–2043. [PubMed] [Google Scholar]
  • 17. Gyorkey F, Cabral GA, Gyorkey PK, Uribe‐Botero G, Dreesman GR, Melnick JL: Coxsackievirus, aggregates in muscle cells of a polymyositis patients. Intervirology 1978; 10: 69–77. [DOI] [PubMed] [Google Scholar]
  • 18. Hirsch TJ, Enlow RW, Bias WB, Arnett FC: HLA‐D related (DR) antigens in various kinds of myositis. Hum Immunol 1981; 3: 181–186. [DOI] [PubMed] [Google Scholar]
  • 19. Hohlfeld R, Engel AG: Induction of HLA‐DR expression on human myoblasts with interferon‐gamma. Am J Pathol 1990; 136: 503–508. [PMC free article] [PubMed] [Google Scholar]
  • 20. Isenberg DA, Rowe D, Shearer M, Novick D, Beverley PCL: Localization of interferons and interleukin‐2 in polymyositis and muscular dystrophy. Clin Exp Immunol 1986; 63: 450–458. [PMC free article] [PubMed] [Google Scholar]
  • 21. Joseph J, Knobler RL, Lublin FD, Hart MN: Differential modulation of MHC class I antigen expression on mouse brain endothelial cells by MHV‐4 infection. J Neuroimmunol 1989; 22: 241–253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Karpati G, Pouliot Y, Carpenter S: Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988; 23: 64–72. [DOI] [PubMed] [Google Scholar]
  • 23. Kesson AM: WNV‐induced modulation of class I major histocompatibility antigens: implications for Tc cell/target cell interactions, T lymphocyte response to flavivirus infections. PhD thesis, Australian National University, Canberra, ACT, 1989, pp 180–205.
  • 24. King NJC, Sinickas VG, Blanden RV: H‐2K and H‐2D antigens are independently regulated in mouse embryo fibroblasts. Exp Clin Immunogen 1985; 2: 206–214. [PubMed] [Google Scholar]
  • 25. King NJC, Müllbacher A, Blanden RV: Relationship between surface H‐2 concentration, size of different target cells, and lysis by cytotoxic T cells. Cell Immunol 1986; 98: 525–532. [DOI] [PubMed] [Google Scholar]
  • 26. King NJC, Kesson AM: Interferon independent increases in class I major histocompatibility complex antigen expression following flavivirus infection. J Gen Virol 1988; 69: 2535–2543. [DOI] [PubMed] [Google Scholar]
  • 27. King NJC, Maxwell LE, Kesson AM: Induction of class I major histocompatibility complex antigen expression by West Nile virus on γ interferon‐refractory early murine trophoblast cells. Proc Natl Acad Sci USA 1989; 86: 911–915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Koszinowski U, Ertl H: Altered serological and cellular reactivity to H‐2 antigens after target cell infection with vaccinia virus. Nature 1975; 257: 596–597. [DOI] [PubMed] [Google Scholar]
  • 29. Liu Y, King NJC, Kesson AM, Blanden RV, Müllbacher A: Flavivirus infection up‐regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro . J Neuroimmunol 1989; 21: 157–168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Massa PT, Dorries R, ter Meulen V: Viral particles induce la antigen expression on astrocytes. Nature 1986; 320: 543–546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Nishikai M, Homma M: Circulating autoantibody against human myoglobin in polymyositis. JAMA 1977; 237: 1842–1844. [PubMed] [Google Scholar]
  • 32. Olsson T, Henriksson KG, Klareskog L: HLA‐DR expression, T lymphocyte phenotypes, OKM1 and OKT9 reactive cells in inflammatory myopathy. Muscle Nerve 1985; 8: 419–425. [DOI] [PubMed] [Google Scholar]
  • 33. O'Neill H, Blanden RV: Quantitative differences in the expression of parentally‐derived H‐2 antigen expression on lymphomyeloid cells in semi‐allogeneic irradiation chimeras. J Exp Med 1979; 149: 724–729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Pääbo S, Nilsson T, Peterson PA: Adenoviruses of subgenera B, C, D, and E modulate cell‐surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci USA 1986; 83: 9665–9669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Pasternack MS, Bevan MJ, Klein JR: Release of discrete interferons by cytotoxic T lymphocytes in response to immune and non‐immune stimuli. J Immunol 1984; 133: 277–280. [PubMed] [Google Scholar]
  • 36. Schubert W, Zimmermann K, Cramer M, Starzinski‐Powitz A: Lymphocyte antigen Leu‐19 as a molecular marker of regeneration in human skeletal muscle. Proc Natl Acad Sci USA 1989; 86: 307–311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Shimonkevitz R, Luescher B, Cerottini J‐C, Robson Mac‐Donald H: Clonal analysis of cytolytic T lymphocyte‐mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt‐2/3 function. J Immunol 1985; 135: 892–899. [PubMed] [Google Scholar]
  • 38. Simpson DM, Bender AN: Human immunodeficiency virus‐associated myopathy: analysis of 11 patients. Ann Neurol 1988; 24: 79–84. [DOI] [PubMed] [Google Scholar]
  • 39. Suzumura A, Lavi E, Weiss SR, Silberberg DH: Coronavirus infection induces H‐2 antigen expression on oligodendrocytes and astrocytes. Science 1986; 232: 991–993. [DOI] [PubMed] [Google Scholar]
  • 40. Suzumura A, Lavi E, Bhar S, Murasko D, Weiss SR, Silberberg DH: Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. J Immunol 1988; 140: 2068–2072. [PubMed] [Google Scholar]
  • 41. Zinkernagel RM, Doherty PC: Restriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974; 248: 701–702. [DOI] [PubMed] [Google Scholar]

Articles from Muscle & Nerve are provided here courtesy of Wiley

RESOURCES